Abstract
Alterations of gamma aminobutyric acid (GABA)-mediated neurotransmission have been implicated in the pathogenesis of epilepsies. Here we examine the distribution of the GABAA receptor in the hippocampus of 78 surgical specimens from patients with chronic pharmacoresistant focal epilepsies. The receptor was localized immunohistochemically with the monoclonal antibody bd-24 which selectively recognizes the α1 subunit of the GABAA receptor. The results were compared with the receptor distribution of 28 normal hippocampal specimens obtained at autopsy. In the great majority of the surgical specimens a loss of GABAA receptor immunoreactivity was present in CA1 (92.3%), CA4 (78.2%), the dentate granular cell layer (70.5%) and the molecular layer of the dentate gyrus (65.4%). The subiculum revealed a normal staining pattern in all but 4 cases. In no instance did we observe an increase of immunoreactivity in any region or cell population. The decrease of GABAA receptor immunoreactivity was closely related to neuronal loss in the respective specimen and to Ammon's horn sclerosis. There was no correlation between GABAA receptor loss and the patient's age at surgery, duration of seizures, age at onset of seizures and to the presence or absence of secondary generalized tonic clonic seizures. The data suggest that the observed loss of GABAA receptor immunoreactivity is a secondary phenomenon rather than an event that is relevant for the pathogenesis of epileptic seizures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Avoli M (1988) GABAergic mechanisms and epileptic discharges. In: Avoli M, et al (eds) Neurotransmitters and cortical function: from molecules to mind. Plenum Press, New York, pp 187–205
Babb TL (1991) Research on the anatomy and pathology of epileptic tissue. In: Lüders H (ed) Epilepsy surgery. Raven Press, New York, pp 719–727
Babb TL, Pretorius JK, Kupfer WR, Feldblum S (1989) Recovery of decreased glutamate decarboxylase immunoreactivity after rat hippocampal kindling. Epilepsy Res 3: 18–30
Bakay R, Harris A (1981) Neurotransmitter, receptor and biochemical changes in monkey cortical epileptic foci. Brain Res 206: 387–404
Bruton CJ (1988) The neuropathology of temporal lobe epilepsy. Oxford University Press, Oxford
Ewert M, Shivers BD, Lueddens H, Moehler H, Seeburg PH (1990) Subunit selectivity and epitope characterization of mAbs directed against the GABAA/benzodiazepine receptor. J Cell Biol 110: 2043–2048
Franck JE, Kunkel DD, Baskin DG, Schwartzkroin PA (1988) Inhibition in kainate-lesioned hyperexcitable hippocampi: physiologic, autoradiographic, and immunocytochemical observations. J Neurosci 8: 1991–2002
Houser CR (1991) GABA neurons in seizure disorders: a review of immunocytochemical studies. Neurochem Res 16: 295–308
Houser CR, Olsen RW, Richards JG, Möhler H (1988) Immunohistochemical localization of benzodiazepine/GABAA receptors in the human hippocampal formation. J Neurosci 8: 1370–1383
Johnson EW, de Lanerolle NC, Kim JH, Sundaresan S, Spencer DD, Mattson RH, Zoghbi SS, Baldwin RM, Hoffer PB, Seibyl JP, Innis RB (1992) “Central” and “peripheral” benzodiazepine receptors: opposite changes in human epileptogenic tissue. Neurology 42:811–815
Lloyd KG, Munari C, Bossi L, Stoeffels C, Talairach J, Morselli PL (1981) Biochemical evidence for alterations of GABA-mediated synaptic transmission in pathological brain tissue (stereo EEG or morphological definition) from epileptic patients. In: Morselli PL, et al (eds) Neurotransmitters, seizures and epilepsy. Raven Press, New York, pp 325–334
Lloyd KG, Bossi L, Morselli PL Munari C, Rougier M, Loiseau H (1986) Alterations of GABA-mediated synaptic transmission in human epilepsy. Adv Neurol 44: 1033–44
Meencke HJ Veith G (1991) Hippocampal sclerosis in epilepsy. In: Lüders H (ed) Epilepsy surgery. Raven Press, New York, pp 705–715
Olsen RW, Bureau M, Houser CR, Delgado-Escueta AV, Richards JG, Möhler H (1992) GABA/benzodiazepine receptors in human focal epilepsy. Epilepsy Res [suppl] 8: 383–391
Sherwin A, Matthew E, Blain M, Guévremont D (1986) Benzodiazepine receptor binding is not altered in human epiletogenic cortical foci. Neurology 36: 1380–1382
Shivers BD, Killisch I, Sprengel R, Sontheimer H, Köhler M, Schofield PR, Seeburg PH (1989) Two novel GABAA receptor subunits exist in distinct neuronal subpopulations. Neuron 3: 327–337
Sieghard W (1990) GABAA-Benzodiazepinrezeptoren und Epilepsie. Wien Klin Wochenschr 102: 197–201
Snodgrass SR (1992) GABA and epilepsy: their complex relationship and the evolution of our understanding. J Child Neurol 7: 77–86
Valdes F, Dasheiff RM, Birmingham F, Crutcher KA, McNamara JO (1982) Benzodiazepine receptor increases after repeated seizures: evidence for localization to dentate granule cells. Proc Natl Acad Sci USA 79: 193–197
Wisden W, Laurie DJ, Monyer H, Seeburg PH (1992) The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci 12: 1040–1062
Wolf HK, Campos MG, Zentner J, Hufnagel A, Schramm J, Elger CE, Wiestler OD (1993) Surgical pathology of temporal lobe epilepsy. Exprience with 216 cases. J Neuropathol Exp Neurol 52: 499–506
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wolf, H.K., Spänle, M., Müller, M.B. et al. Hippocampal loss of the GABAA receptor α1 subunit in patients with chronic pharmacoresistant epilepsies. Acta Neuropathol 88, 313–319 (1994). https://doi.org/10.1007/BF00310375
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00310375